American Journal of Cardiovascular Drugs

, Volume 12, Issue 5, pp 345–348 | Cite as

High Prevalence of Silent Brain Infarction in Patients Presenting with Mechanical Heart Valve Thrombosis

  • Parag Barwad
  • Amol Raheja
  • Raghunandan Venkat
  • Shyam S. Kothari
  • Vinay Bahl
  • Ganesan Karthikeyan
Short Communication
  • 36 Downloads

Abstract

Background: Symptomatic thromboembolic events including stroke occur frequently in patients with mechanical heart valves, particularly among those who are poorly anticoagulated.

Objective: This study set out to determine the prevalence of silent brain infarction (SBI) in this population.

Methods: This was a post hoc analysis of data from a randomized controlled trial carried out in a tertiary-care academic medical center. The trial included participants from a randomized controlled trial of fibrinolytic therapy (FT) in patients with left-sided prosthetic valve thrombosis (PVT), who had undergone pre-treatment computed tomography (CT) scans of the brain. The prevalence of SBI in this population was investigated.

Main Outcome Measure: Prevalence of silent brain infarction.

Results: Silent brain infarction was present in 27 of 72 patients (37.5%; 95% confidence interval [CI] 27.2, 49.1). Most patients with SBI (57; 82.6%) had sub-therapeutic anticoagulation at presentation. We identified baseline characteristics that were associated with the presence of SBI using a logistic regression model. Atrial fibrillation (AF) was strongly associated with the presence of SBI (odds ratio [OR] 5.60; 95% CI 1.32, 23.87; p= 0.02).

Conclusion: The high prevalence of SBI among this cohort of young patients with mechanical heart valves is alarming and calls for urgent efforts to improve the quality of anticoagulation.

Clinical Trial Registration: Registered in the US National Institutes of Health registry at http://clinicaltrials.gov as NCT00232622.

References

  1. 1.
    Vermeer SE, Longstreth Jr WT, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007 Jul; 6 (7): 611–9PubMedCrossRefGoogle Scholar
  2. 2.
    Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994 Feb; 89 (2): 635–41PubMedCrossRefGoogle Scholar
  3. 3.
    Edmunds Jr LH. Thromboembolic complications of current cardiac valvular prostheses. Ann Thorac Surg 1982 Jul; 34 (1): 96–106PubMedCrossRefGoogle Scholar
  4. 4.
    Burchfiel CM, Hammermeister KE, Krause-Steinrauf H, et al. Left atrial dimension and risk of systemic embolism in patients with a prosthetic heart valve. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease. J Am Coll Cardiol. 1990 Jan; 15 (1): 32–41Google Scholar
  5. 5.
    Karthikeyan G, Math RS, Mathew N, et al. Accelerated infusion of streptokinase for the treatment of left-sided prosthetic valve thrombosis: a randomized controlled trial. Circulation 2009 Sep 22; 120 (12): 1108–14PubMedCrossRefGoogle Scholar
  6. 6.
    Akdemir I, Dagdelen S, Yuce M, et al. Silent brain infarction in patients with rheumatic mitral stenosis. Jpn Heart J 2002 Mar; 43 (2): 137–44PubMedCrossRefGoogle Scholar
  7. 7.
    Bernick C, Kuller L, Dulberg C, et al. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology 2001 Oct 9; 57 (7): 1222–9PubMedCrossRefGoogle Scholar
  8. 8.
    Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003 May; 34 (5): 1126–9PubMedCrossRefGoogle Scholar
  9. 9.
    Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003 Mar 27; 348 (13): 1215–22PubMedCrossRefGoogle Scholar
  10. 10.
    Wallentin L, Yusuf S, Ezekowitz MD, et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet 2010 Sep 18; 376 (9745): 975–83PubMedCrossRefGoogle Scholar
  11. 11.
    Talwar S, Kapoor CK, Velayoudam D, et al. Anticoagulation protocol and early prosthetic valve thrombosis. Indian Heart J 2004 May–Jun; 56 (3): 225–8PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2012

Authors and Affiliations

  • Parag Barwad
    • 1
  • Amol Raheja
    • 1
  • Raghunandan Venkat
    • 1
  • Shyam S. Kothari
    • 1
  • Vinay Bahl
    • 1
  • Ganesan Karthikeyan
    • 1
  1. 1.Department of CardiologyAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations